Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memory Pharm CorpfiledCriticalMemory Pharm Corp
Publication of ECSP034698ApublicationCriticalpatent/ECSP034698A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La inhibición de PDE4 se logra por nuevos compuestos, por ejemplo, análogos de anilina y difenilamina N-Sustituidas. Los compuestos de la presente invención son de la fórmula I: Donde R1, R2, R3 y R4 tienen los valores que se definen en la presente.The inhibition of PDE4 is achieved by new compounds, for example, N-Substituted aniline and diphenylamine analogs. The compounds of the present invention are of the formula I: Where R1, R2, R3 and R4 have the values defined herein.